News
SNWV
5.73
-2.55%
-0.15
Weekly Report: what happened at SNWV last week (0803-0807)?
Weekly Report · 19h ago
Sanuwave Health Q2 Earnings Call Highlights
NASDAQ · 3d ago
SANUWAVE Health GAAP EPS of -$0.08, revenue of $9.74M
Seeking Alpha · 4d ago
*SANUWAVE Health 2Q Loss/Shr 8c >SNWV
Dow Jones · 4d ago
Press Release: Sanuwave Announces Q2 FY2026 Financial Results
Dow Jones · 4d ago
Press Release: Sanuwave Announces Q2 FY2026 -2-
Dow Jones · 4d ago
Weekly Report: what happened at SNWV last week (0727-0731)?
Weekly Report · 08/03 10:10
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
Barchart · 07/30 17:00
Weekly Report: what happened at SNWV last week (0720-0724)?
Weekly Report · 07/27 10:14
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/23 12:06
Weekly Report: what happened at SNWV last week (0713-0717)?
Weekly Report · 07/20 10:11
What's Going On With SANUWAVE Health Stock On Friday?
Benzinga · 07/17 13:42
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/15 17:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 07/14 21:05
Sanuwave's Preliminary Q2 Revenue Slips Year Over Year But Tops Revised Guidance; Stock Up
NASDAQ · 07/14 14:07
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/13 21:05
Sanuwave sees Q2 revenue up to $9.8M
Seeking Alpha · 07/13 20:50
SANUWAVE Health Raises Q2 Sales Guidance from $8.500M-$9.500M to $9.600M-$9.800M
Benzinga · 07/13 20:48
Sanuwave Health sees Q2 revenue $9.6M-$9.8M
TipRanks · 07/13 20:35
*SANUWAVE Health Sees 2Q Rev $9.6M-$9.8M >SNWV
Dow Jones · 07/13 20:30
More
Webull provides a variety of real-time SNWV stock news. You can receive the latest news about Sanuwave Health through multiple platforms. This information may help you make smarter investment decisions.
About SNWV
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.